Please Wait.....
Report
Ablation Technology Market Assessment, By Product [Radiofrequency Ablators, Ultrasound Ablators, Laser/Light Ablators, Electrical Ablators, Cryoablation Devices, Microwave Ablators, Hydrothermal/Hydromechanical Ablators, Consumables], By Application [Cardiovascular Disease Treatment, Cancer Treatment, Ophthalmological Treatment, Pain Management, Urological Treatment, Orthopedic Treatment, Cosmetic/Aesthetic Surgery, Others], By End-user [Hospitals, Surgical Centers, and Ablation Centers, Ambulatory Surgery Centers, Aesthetics and Dermatology Clinics, Others], By Region, Opportunities and Forecast, 2018-2032F
Market Report I 2025-04-22 I 227 Pages I Market Xcel - Markets and Data
Global ablation technology market is projected to witness a CAGR of 8.70% during the forecast period 2025-2032, growing from USD 7.88 billion in 2024 to USD 15.37 billion in 2032 owing to the increasing demand for minimally invasive procedures, rising regulatory approvals for advanced devices, and a surge in strategic partnerships between medical device companies and healthcare providers. Additionally, the growing prevalence of chronic diseases like cancer and cardiovascular conditions contributes to market growth.
For instance, in March 2025, Abbott received CE mark approval in Europe for the Volt PFA System, developed to treat atrial fibrillation. This milestone highlights Abbott's progress in advancing electrophysiology and supports its plans to broaden Volt's availability across European countries later in the year.
Rising Regulatory Approvals for Ablation Technologies
The global ablation technology market is experiencing a surge in growth due to the rising number of regulatory approvals for innovative and advanced ablation devices. Health authorities like the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly granting approvals for novel devices aimed at treating a variety of diseases, including cancer, cardiovascular conditions, and neurological disorders. These regulatory advancements not only enhance the credibility of these products but also pave the way for their widespread adoption in healthcare settings worldwide. As new technologies are introduced and validated, healthcare providers are more inclined to adopt cutting-edge solutions that offer higher efficiency, improved patient outcomes, and enhanced safety. This increased approval activity for new technologies and devices, such as advanced cryoablation systems or radiofrequency ablation tools, fosters innovation and ensures that healthcare professionals have access to the best possible treatments. Moreover, the growth of minimally invasive techniques and the preference for non-surgical interventions further accelerates market expansion, particularly in the treatment of chronic diseases and tumors. For instance, in January 2025, Johnson & Johnson (U.S.) secured CE mark certification for its THERMOCOOL SMARTTOUCH SF catheter, intended for the treatment of cardiac arrhythmias, enabling further adoption across European markets.
Rise in Strategic Partnerships and Collaborations
The rise in strategic partnerships and collaborations is a key driver fueling growth in the global ablation technology market. As healthcare providers and manufacturers collaborate, there is a mutual exchange of resources, expertise, and technology that accelerates the development and commercialization of advanced ablation devices. These partnerships often include collaborations between medical device companies, academic institutions, and healthcare providers, leading to faster innovation and enhanced product offerings. For example, alliances with research institutions can lead to breakthroughs in ablation technologies, such as improved imaging systems or more effective energy delivery methods. Additionally, joint ventures with healthcare providers ensure that new devices and techniques are rapidly integrated into clinical practice. The benefits of these collaborations include expanded research and development capabilities, enhanced distribution networks, and access to new patient populations. The result is an accelerated market penetration of new ablation technologies, along with the assurance of effective and reliable treatments for patients. This collaborative approach is expected to continue driving market dynamics, with more partnerships emerging as the demand for innovative and effective therapies grows.
For instance, in February 2025, Japan Lifeline Co., Ltd. announced a strategic partnership with CardioFocus, Inc., focused on Pulsed Field Ablation (PFA) technology. Japan Lifeline has obtained licensing rights to CardioFocus's PFA System as part of this alliance, including PFA catheters and a generator. The two companies will work together on developing, producing, and distributing these systems, aiming to build a foundation for global commercialization in the future.
Expansion of Tumour Ablation Applications
The increasing prevalence of cancer has led to a significant expansion in the applications of tumor ablation technologies, particularly in minimally invasive treatments for liver, lung, kidney, and bone tumors. This shift is driven by the advantages of ablation procedures, such as reduced recovery times and lower complication rates compared to traditional surgeries. For instance, in March 2024, Medtronic plc received FDA 510(k) clearance for its OsteoCool 2.0 system, an advanced radiofrequency ablation device designed for the treatment of painful bone metastases and benign bone tumors. This approval underscores the growing adoption of ablation technologies in oncology, reflecting their efficacy and expanding role in cancer care.
North America Leading the Ablation Technology Market
North America is anticipated to maintain its leadership in the global ablation technology market, owing to its advanced healthcare infrastructure, high levels of healthcare spending, and widespread adoption of minimally invasive procedures. The increasing prevalence of chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, which require ablation treatments, further strengthens the region's dominance. Additionally, favorable reimbursement policies and the strong presence of major market players, including Medtronic and Boston Scientific, contribute significantly to the region's growth. The rapid integration of advanced technologies, such as robotic-assisted and cryoablation devices, further enhances treatment outcomes, making North America a key market for innovative ablation solutions. With continuous advancements in research, the region is expected to maintain a competitive edge and drive substantial market growth in the coming years. Furthermore, strategic collaborations and partnerships between healthcare providers and leading device manufacturers further solidify North America's position as a global leader in ablation technology.
Future Market Scenario (2025-2032F)
The global ablation technology market is poised for substantial growth as technological advancements, increasing regulatory approvals, and expanding healthcare infrastructure drive adoption across diverse therapeutic applications. The demand for minimally invasive procedures, coupled with rising cases of chronic diseases and cancers, will continue to propel market expansion. Additionally, integrating artificial intelligence and robotics into ablation systems is expected to enhance precision and patient outcomes, further fueling market development. The market will also witness increased penetration in emerging economies. For instance, in September 2024, Boston Scientific Corporation (U.S.) received regulatory clearance from Japan's PMDA for its FARAPULSE Pulsed Field Ablation System, enabling the use of the device in pulmonary vein isolation procedures for paroxysmal atrial fibrillation.
Key Players Landscape and Outlook
The key players in the market are significantly investing in the development of ablation technology and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.
In November 2023, Johnson & Johnson MedTech (US) completed the acquisition of Laminar, Inc. (US), integrating the company into its Biosense Webster division to enhance its cardiac arrhythmia treatment portfolio and better address unmet clinical needs.
1. Project Scope and Definitions
2. Research Methodology
3. Executive Summary
4. Global Ablation Technology Market Outlook, 2018-2032F
4.1. Market Size Analysis & Forecast
4.1.1. By Value
4.2. Market Share Analysis & Forecast
4.2.1. By Product
4.2.1.1. Radiofrequency Ablators
4.2.1.1.1. Temperature-Controlled Radiofrequency Ablators
4.2.1.1.2. Fluid-Cooled Radiofrequency Ablators
4.2.1.1.3. Robotic Catheter Manipulation Systems
4.2.1.2. Ultrasound Ablators
4.2.1.2.1. Ultrasonic Surgical Ablation Systems
4.2.1.2.2. High-Intensity Focused Ultrasound Ablators
4.2.1.2.3. Extracorporeal Shockwave Lithotripsy Systems
4.2.1.2.4. Magnetic Resonance-Guided Focused Ultrasound Ablators
4.2.1.3. Laser/Light Ablators
4.2.1.3.1. Excimer Laser Ablators
4.2.1.3.2. Cold Laser Ablators
4.2.1.4. Electrical Ablators
4.2.1.4.1. Argon Plasma/Beam Coagulators
4.2.1.4.2. Irreversible Electroporation Ablators
4.2.1.5. Cryoablation Devices
4.2.1.5.1. Tissue Contact Probes
4.2.1.5.2. Tissue Spray Probe
4.2.1.5.3. Epidermal and Subcutaneous Cryoablation Devices
4.2.1.6. Microwave Ablators
4.2.1.7. Hydrothermal/Hydromechanical Ablators
4.2.1.8. Consumables
4.2.2. By Application
4.2.2.1. Cardiovascular Disease Treatment
4.2.2.2. Cancer Treatment
4.2.2.2.1. Liver Cancer
4.2.2.2.2. Kidney Cancer
4.2.2.2.3. Prostate Cancer
4.2.2.2.4. Lung Cancer
4.2.2.2.5. Others
4.2.2.3. Ophthalmological Treatment
4.2.2.4. Pain Management
4.2.2.5. Urological Treatment
4.2.2.6. Orthopedic Treatment
4.2.2.7. Cosmetic/Aesthetic Surgery
4.2.2.8. Others
4.2.3. By End-user
4.2.3.1. Hospitals, Surgical Centers, and Ablation Centers
4.2.3.2. Ambulatory Surgery Centers
4.2.3.3. Aesthetics and Dermatology Clinics
4.2.3.4. Others
4.2.4. By Region
4.2.4.1. North America
4.2.4.2. Europe
4.2.4.3. Asia-Pacific
4.2.4.4. South America
4.2.4.5. Middle East and Africa
4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
4.3. Market Map Analysis, 2024
4.3.1. By Product
4.3.2. By Application
4.3.3. By End-user
4.3.4. By Region
5. North America Ablation Technology Market Outlook, 2018-2032F
5.1. Market Size Analysis & Forecast
5.1.1. By Value
5.2. Market Share Analysis & Forecast
5.2.1. By Product
5.2.1.1. Radiofrequency Ablators
5.2.1.1.1. Temperature-Controlled Radiofrequency Ablators
5.2.1.1.2. Fluid-Cooled Radiofrequency Ablators
5.2.1.1.3. Robotic Catheter Manipulation Systems
5.2.1.2. Ultrasound Ablators
5.2.1.2.1. Ultrasonic Surgical Ablation Systems
5.2.1.2.2. High-Intensity Focused Ultrasound Ablators
5.2.1.2.3. Extracorporeal Shockwave Lithotripsy Systems
5.2.1.2.4. Magnetic Resonance-Guided Focused Ultrasound Ablators
5.2.1.3. Laser/Light Ablators
5.2.1.3.1. Excimer Laser Ablators
5.2.1.3.2. Cold Laser Ablators
5.2.1.4. Electrical Ablators
5.2.1.4.1. Argon Plasma/Beam Coagulators
5.2.1.4.2. Irreversible Electroporation Ablators
5.2.1.5. Cryoablation Devices
5.2.1.5.1. Tissue Contact Probes
5.2.1.5.2. Tissue Spray Probe
5.2.1.5.3. Epidermal and Subcutaneous Cryoablation Devices
5.2.1.6. Microwave Ablators
5.2.1.7. Hydrothermal/Hydromechanical Ablators
5.2.1.8. Consumables
5.2.2. By Application
5.2.2.1. Cardiovascular Disease Treatment
5.2.2.2. Cancer Treatment
5.2.2.2.1. Liver Cancer
5.2.2.2.2. Kidney Cancer
5.2.2.2.3. Prostate Cancer
5.2.2.2.4. Lung Cancer
5.2.2.2.5. Others
5.2.2.3. Ophthalmological Treatment
5.2.2.4. Pain Management
5.2.2.5. Urological Treatment
5.2.2.6. Orthopedic Treatment
5.2.2.7. Cosmetic/Aesthetic Surgery
5.2.2.8. Others
5.2.3. By End-user
5.2.3.1. Hospitals, Surgical Centers, and Ablation Centers
5.2.3.2. Ambulatory Surgery Centers
5.2.3.3. Aesthetics and Dermatology Clinics
5.2.3.4. Others
5.2.4. By Country Share
5.2.4.1. United States
5.2.4.2. Canada
5.2.4.3. Mexico
5.3. Country Market Assessment
5.3.1. United States Ablation Technology Market Outlook, 2018-2032F*
5.3.1.1. Market Size Analysis & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share Analysis & Forecast
5.3.1.2.1. By Product
5.3.1.2.1.1. Radiofrequency Ablators
5.3.1.2.1.1.1. Temperature-Controlled Radiofrequency Ablators
5.3.1.2.1.1.2. Fluid-Cooled Radiofrequency Ablators
5.3.1.2.1.1.3. Robotic Catheter Manipulation Systems
5.3.1.2.1.2. Ultrasound Ablators
5.3.1.2.1.2.1. Ultrasonic Surgical Ablation Systems
5.3.1.2.1.2.2. High-Intensity Focused Ultrasound Ablators
5.3.1.2.1.2.3. Extracorporeal Shockwave Lithotripsy Systems
5.3.1.2.1.2.4. Magnetic Resonance-Guided Focused Ultrasound Ablators
5.3.1.2.1.3. Laser/Light Ablators
5.3.1.2.1.3.1. Excimer Laser Ablators
5.3.1.2.1.3.2. Cold Laser Ablators
5.3.1.2.1.4. Electrical Ablators
5.3.1.2.1.4.1. Argon Plasma/Beam Coagulators
5.3.1.2.1.4.2. Irreversible Electroporation Ablators
5.3.1.2.1.5. Cryoablation Devices
5.3.1.2.1.5.1. Tissue Contact Probes
5.3.1.2.1.5.2. Tissue Spray Probe
5.3.1.2.1.5.3. Epidermal and Subcutaneous Cryoablation Devices
5.3.1.2.1.6. Microwave Ablators
5.3.1.2.1.7. Hydrothermal/Hydromechanical Ablators
5.3.1.2.1.8. Consumables
5.3.1.2.2. By Application
5.3.1.2.2.1. Cardiovascular Disease Treatment
5.3.1.2.2.2. Cancer Treatment
5.3.1.2.2.2.1. Liver Cancer
5.3.1.2.2.2.2. Kidney Cancer
5.3.1.2.2.2.3. Prostate Cancer
5.3.1.2.2.2.4. Lung Cancer
5.3.1.2.2.2.5. Others
5.3.1.2.2.3. Ophthalmological Treatment
5.3.1.2.2.4. Pain Management
5.3.1.2.2.5. Urological Treatment
5.3.1.2.2.6. Orthopedic Treatment
5.3.1.2.2.7. Cosmetic/Aesthetic Surgery
5.3.1.2.2.8. Others
5.3.1.2.3. By End-user
5.3.1.2.3.1. Hospitals, Surgical Centers, and Ablation Centers
5.3.1.2.3.2. Ambulatory Surgery Centers
5.3.1.2.3.3. Aesthetics and Dermatology Clinics
5.3.1.2.3.4. Others
5.3.2. Canada
5.3.3. Mexico
*All segments will be provided for all regions and countries covered
6. Europe Ablation Technology Market Outlook, 2018-2032F
6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Turkey
6.9. Poland
7. Asia-Pacific Ablation Technology Market Outlook, 2018-2032F
7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines
8. South America Ablation Technology Market Outlook, 2018-2032F
8.1. Brazil
8.2. Argentina
9. Middle East and Africa Ablation Technology Market Outlook, 2018-2032F
9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
10. Demand Supply Analysis
11. Import and Export Analysis
12. Value Chain Analysis
13. Porter's Five Forces Analysis
14. PESTLE Analysis
15. Pricing Analysis
16. Market Dynamics
16.1. Market Drivers
16.2. Market Challenges
17. Market Trends and Developments
18. Regulatory Landscape and Innovation
19. Case Studies
20. Patient Epidemiology Data for Key Disease Indications
21. Competitive Landscape
21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
21.3.1. Johnson & Johnson Services, Inc.
21.3.1.1. Company Details
21.3.1.2. Key Management Personnel
21.3.1.3. Products and Services
21.3.1.4. Financials (As Reported)
21.3.1.5. Key Market Focus and Geographical Presence
21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
21.3.2. Medtronic plc
21.3.3. Boston Scientific Corporation
21.3.4. AngioDynamics, Inc.
21.3.5. Olympus Corporation
21.3.6. AtriCure, Inc.
21.3.7. Smith and Nephew plc
21.3.8. Accuray Incorporated
21.3.9. Conmed Corporation
21.3.10. Varian Medical Systems, Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
22. Strategic Recommendations
23. About Us and Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security